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Phellinus linteus, a mushroom, contains constituents that exhibit potent antitumor effects through
activating immune cells. Recently, anti-inflammatory and anti-allergic properties of P. linteus extracts
have also been implicated. In the present study, therefore, we separated the constituents of mycelium
of P. linteus into five fractions—chloroform-soluble (CF), ethyl acetate-soluble (EA), methanol-
soluble (AE), water-soluble (WA) and boiling water-soluble (BW) fractions—and examined their sup-
pressive effects on the IgE-dependent mouse triphasic cutaneous reaction. The triphasic reaction was
induced in the ear of BALB/c mice passively sensitized with anti-dinitrophenol IgE by painting with
2,4-dinitrofluorobenzene 24 h later. Ear swelling appeared triphasically with peak responses at 1 h,
24 h and 8 days after the challenge. ME, WA and BW given orally at a dose of 100 mg kg
 1 significantly
inhibitedthefirst andsecond phaseear swelling,andBW alsoinhibitedthe thirdphase response. CFonly
inhibited the second phase. The inhibition by BW was the most potent and almost dose-dependent at
doses of 30–300 mg kg
 1. BW also inhibited vascular permeability increase caused by passive cutane-
ous anaphylaxis and histamine, and ear swelling caused by tumor necrosis factor-a. In contrast,
BW apparently potentiated the production of interleukin-4 and interferon-g from anti-CD3-stimulated
mouse splenocytes. These results indicate that BW derived from mycelium of P. linteus contains
some constituents with anti-allergic as well as immunopotentiating properties.
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Introduction
Phellinus linteus, a mushroom, has been known to exhibit a
potent antitumor activity and polysaccharides involved are
considered to be the active constituents (1–4). The antitumor
activity of P. linteus has been ascribed to an immunopotentiat-
ing effect because P. linteus polysaccharides exhibit activating
effects on immune cells such as T lymphocytes, B lympho-
cytes, natural killer cells, macrophages and dendritic cells
(5–8). Recently, direct mechanisms for the antitumor activities
of P. linteus have also been recognized (9,10).
In contrast to the immunopotentiating properties of
P. linteus, anti-inflammatory and anti-allergic properties of
P. linteus have rarely been investigated. In 2004, Kim et al.
(11) reported that n-butanol fraction of P. linteus dose-
dependently inhibits croton oil-induced mouse ear edema. In
2003, Kim et al. (12) reported that oral administration of pro-
teoglycan isolated from P. linteus inhibits collagen-induced
mouse arthritis and that the inhibition is associated with
reduced serum IgG1 and IgG2a levels and reduced production
of tumor necrosis factor-a (TNF-a) and interferon-g (IFN-g)
in lymph node cells. Furthermore, P. linteus extract reduces
IgE production that may be associated with increased IFN-g
production (13). These reports strongly suggest that P. linteus
possesses anti-allergic and/or anti-inflammatory properties
as well as immunomodulating properties.
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stituents of cultured mycelium of P. linteus (4) and examined
the anti-allergic properties using the IgE-dependent mouse
triphasic cutaneous reaction (14,15).
Methods
Mice
Male and female BALB/c and male ddY mice, 6 weeks of age,
were obtained from Japan SLC Inc. (Hamamatsu, Japan) and
maintained for 2 weeks before the start of experiments. They
were housed in an air-conditioned animal room with a tem-
perature of 22 ± 1 C and a humidity of 60 ± 5%, and fed
laboratory diet and water ad libitum. Experiments were under-
taken following the guidelines for the care and use of experi-
mental animals of the Japanese Association for Laboratory
AnimalScience (1987) (16) with an approval by the committee
of our university.
Fractionation of Mycelium of P. linteus
MyceliumofP. linteus(strain PL-08, IBICo.,Ltd,Yamanashi,
Japan) cultured in a medium (4% glucose, 0.3% dried yeast
extract, 0.3% polypeptone, 0.05% potassium dihydrogen-
phosphate, 0.05% disodium hydrogenphosphate, pH 5.5) was
separated by centrifugation and dried (4). Constituents of the
dried mycelium were extracted sequentially with chloroform
(CF), ethyl acetate (EA), methanol (ME), water (WA) and
boiling water (BW), and then the fractions were freeze-dried.
The procedure and amount of each fraction obtained are
summarized in Fig. 1. The fractions were dissolved or sus-
pended in water and administered to mice orally.
Drugs and Reagents
As reference drugs, prednisolone (sodium succinate,
Shionogi & Co., Ltd, Osaka, Japan) and diphenhydramine
(hydrochloride, Sigma-Aldrich Co., St Louis, MO, USA)
were used. They were prepared in water and administered
to mice orally. For causing cutaneous reactions, histamine
(dihydrochloride, Nacalai Tesque, Inc., Kyoto, Japan) and
TNF-a (Techne Co., Minneapolis, MN, USA) were used.
Anti-CD3 antibodies (anti-mouse CD3e hamster IgG) were
purchased from eBioscience, Inc. (San Diego, CA, USA).
IgE and Antigens
Mouse anti-dinitrophenol(DNP) monoclonal IgEwasobtained
by culturing IgE-producing cells, EC-1, as reported previously
(17). IgE titer of the preparation was 1:1024 as estimated by
passive cutaneous anaphylaxis (PCA) in rats. For the induction
of IgE-dependent cutaneous reactions, 2,4-dinitrofluoro-
benzene (DNFB, Nacalai Tesque) and DNP-conjugated bovine
serum albumin (DNP-BSA) were used.
IgE-dependent Triphasic Cutaneous
Reaction in the Mouse Ear
IgE-dependent triphasic cutaneous reactioninthe ear offemale
BALB/c mice was induced as reported previously (14,15,17).
In brief, mice were passively sensitized by injecting 1 ml of
mouse anti-DNP monoclonal IgE preparation intravenously.
Twenty-four hours later, cutaneous reaction was evoked by
painting with 25 ml of 0.15% DNFB acetone-olive oil (3:1)
solution onto each surface of both ear lobes. Ear thickness
was measured before and after the DNFB challenge using a
micrometer (Ozaki MFG Co., Ltd, Tokyo, Japan).
PCA in the Mouse Ear
PCA was induced in the ear of male ddY mice as reported
previously (18,19). Appropriately diluted mouse anti-DNP
monoclonal IgE preparation at a volume of 10 ml was injected
into both ear lobes for sensitization. Twenty-four hours later,
0.25 ml of 0.1 mg ml
 1 DNP-BSA saline solution containing
boiling water-soluble residue [1 6 . 2 1g]
mycelium of Phellinus linteus
extracted with chloroform
[ 1 kg ]
chloroform-soluble residue
extracted with ethyl acetate
[ 16.31 g ]
ethylacetate-soluble residue
extracted with methanol
[1 . 6 3g]
methanol-soluble residue
extracted with water
[2 2 1 . 5 2g]
water-soluble residue
extracted with boiling water
[6 7 . 7 7g]
CF
EA
ME
WA
BW
Figure 1. Fractionation of constituents of mycelium of P. linteus and the amount of each fraction obtained.
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permeability increase in the ear was assessed by measuring
the amount of extravasated dye 30 min after the challenge.
Cutaneous Reactions Caused by Histamine
and TNF-a in the Mouse Ear
Histamine-induced vascular permeability increase was
observed in the ear of male ddY mice (18,20). In brief, 10 ml
of 10
 4 gm l
 1 histamine saline solution was injected into
both ear lobes. At the same time, 0.25 ml of 0.5% Evans blue
saline solution was injected intravenously. The amount of
extravasated dye for 30 min after the histamine injection was
measured.
TNF-a-induced cutaneous reaction was observed in the ear
of male BALB/c mice (21). Ten microliters of 10
 5 gm l
 1
TNF-a saline solution was injected into both ear lobes and
the increase in ear thickness was assessed 24 h later using a
micrometer.
Cytokine Production in Mouse Splenocytes
Spleen was excised from intact male BALB/c mice and spleno-
cytes were suspended in RPMI-1640 medium supplemented
with fetal calf serum at 10%. Splenocytes at a concentration
of 2.5 · 10
6 cells ml
 1 were incubated for 48 h in the presence
of 1.5 mgm l
 1 anti-CD3 antibodies. After the incubation,
interleukin-4 (IL-4) and IFN-g in the supernatant were quanti-
fied using commercial enzyme-linked immunosorbent assay
kits (Endogen Inc., Woburn, MA, USA), and viable cells were
counted.
Statistics
Results were expressed as the mean ± SEM. Statistical evalu-
ation of data was performed using InStat Program (GraphPad
Software, San Diego, CA, USA). Comparison of data among
threeormoregroups wasperformedusing Dunnett’s orDunn’s
multiple comparison test after confirming the variance of data
by Bartlet’s test. Comparison of data between two groups was
performed by Student’s or Welch’s t-test based on the variance
of data examined by F-test. When the P-value was <0.05 the
difference was considered to be significant.
Results
Inhibition of Triphasic Cutaneous Reaction by
Fraction BW Derived from P. linteus
Effects of five fractions—CF, EA, ME, WA and BW—on the
triphasic cutaneous reaction were investigated. The fractions
and prednisolone were administered orally 1 and 2 h, respect-
ively, before DNFB challenge. The dose for fractions was
100 mg kg
 1 except for EA, which was given at a dose of
50 mg kg
 1 because of the limited amount obtained. Results
are shown in Fig. 2. Upon challenge with DNFB, ear swelling
appeared triphasically with peak responses at 1 h, 24 h and
8 days after the challenge. ME, WA and BW at a dose of
100 mg kg
 1 significantly inhibited the first and second phase
ear swelling, and BW also inhibited the third phase response.
CF at a dose of 100 mg kg
 1 inhibited only the second phase
response. Prednisolone at a dose of 5 mg kg
 1 inhibited all
three phase responses potently. As the inhibition by ME,
WA, BW and prednisolone in the first phase response and
prednisolone in the second phase response was expressed
potently, the ear thickness was reduced under the prevalue.
Results of a dose–response study on BW are indicated in
Fig. 3. BW at doses of 30–300 mg kg
 1 was given orally 1 h
before challenge. BW inhibited all three phases almost
dose-dependently. Prednisolone given 2 h before inhibited
the three phases significantly.
Inhibition of PCA and Histamine-induced
Cutaneous Reaction by BW
Effects of BW on vascular permeability increase associated
with PCA and caused by histamine were investigated. BW and
diphenhydramine were administered orally 1 h and 30 min,
respectively, before eliciting the reaction. Results of PCA are
Pred
BW
WA
ME
EA
CF
Control
Vehicle
100 mg/kg
100 mg/kg
50 mg/kg
100 mg/kg
100 mg/kg
5m g / k g
8d
*
*
0123
24hr
**
**
**
**
*
-1 0 1 2
1h r
**
**
**
**
-2 -1 0 1
Ear swelling (X0.01 mm)
Figure 2. Effects of fractions prepared from mycelium of P. linteus and prednisolone on triphasic cutaneous reaction in the ear of BALB/c mice. Fractions and
prednisolone were administered orally 1 and 2 h before challenge, respectively. EA was given at a dose of 50 mg kg
 1 because of the limited amount obtained.
Each value represents the mean ± SEM for seven or eight mice. *P<0.05, **P<0.01.
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 1 inhibited the
vascular permeability increase dose-dependently. As shown
in Fig. 4B, histamine-induced vascular permeability increase
was also inhibited by BW dose-dependently. Diphenhydram-
ine at a dose of 20 mg kg
 1 inhibited the vascular permeability
increase associated with PCA and induced by histamine
injection potently.
Inhibition of TNF-a-induced Cutaneous
Reactions by BW
Effects of BW on TNF-a-induced ear swelling were investig-
ated. Injection of TNF-a into the ear lobe of mice caused an
ear swelling with a peak response at  24 h later. BW and pred-
nisolone were administered 1 h before TNF-a injection. As
shown in Fig. 5, BW at doses of 30 and 300 mg kg
 1 inhibited
the ear swelling significantly and at 100 mg kg
 1 a tendency of
inhibition was observed. Prednisolone at a dose of 5 mg kg
 1
potently inhibited the TNF-a-induced ear swelling.
5m g / k g Pred
300 mg/kg
100 mg/kg
Control
Saline
30 mg/kg BW
00 . 511 . 522 . 53
*
*
*
8d
00 . 511 . 52
**
*
**
**
24 hr
00 . 511 . 52
*
**
**
1h r
Ear swelling (X0.01 mm)
Figure 3. Effects of fraction BW and prednisolone on triphasic cutaneous reaction in the ear of BALB/c mice BW and prednisolone were administered orally
1 and 2 h before challenge, respectively. Each value represents the mean ± SEM for seven or eight mice. *P<0.05, **P<0.01.
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Figure 4. Effects of fraction BW and diphenhydramine on vascular permeability increase caused by PCA and histamine in male ddY mice. Vascular permeability
increase was cause by PCA (A) and histamine injection (B) in the mouse ear. BW and diphenhydramine were administered orally 1 h and 30 min, respectively,
before eliciting the reaction. Each value represents the mean ± SEM for three or seven mice. *P<0.05, **P<0.01.
300 mg/kg
100 mg/kg
Control (TNF-α)
Saline
30 mg/kg BW
5m g / k g Pred
Ear swelling (X0.01 mm)
**
*
**
0 0.5 1 1.5 2 2.5
Figure 5. Effects of fraction BW and prednisolone on ear swelling caused by
TNF-ain maleBALB/cmiceBW andprednisolonewere administered orally1
h before TNF-a injection. Each value represents the mean ± SEM for seven
mice. *P<0.05, **P<0.01.
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Splenocytes by BW
Effects of BW on anti-CD3-induced cytokine production in
mouse splenocytes were investigated. Splenocytes, 2.5 ·
10
6 cells per well, were incubated for 48 h in the presence
of anti-CD3 antibodies. BW at concentrations from 10
 6 to
10
 4 gm l
 1 and prednisolone at concentration from 10
 8 to
10
 6 M were added to wells 1 h before addition of anti-CD3
antibodies. As shown in Fig. 6, during the incubation period,
although the number of viable cells reduced to 80% in the
absence of anti-CD3 antibodies, anti-CD3 stimulation caused
an increase in cell number  2-fold. Incubation with BW did
not affect the increase, but prednisolone showed a tendency
of concentration-dependent inhibition. Anti-CD3 stimulation
induced IL-4 and IFN-g production in splenocytes. BW poten-
tiated the production of both cytokines in a concentration-
dependent manner, and the potentiation was apparent at
concentrations of 10
 5 and 10
 4 gm l
 1. In contrast, predniso-
lone potently inhibited the anti-CD3-induced cytokine produc-
tion in a concentration-dependent manner.
Discussion
In the present study, we separated the constituents ofmycelium
of P. linteus into five fractions and examined their suppressive
effects on the IgE-dependent mouse triphasic cutaneous reac-
tion. Present results clearly indicated that the BW fraction con-
tains constituents responsible for inhibiting all three phases of
the cutaneous responses most potently.
In mice systemically sensitized with anti-DNP IgE, ear
swelling appears triphasically upon challenge with DNFB
(14,15). The first phase ear swelling appears immediately after
the challenge. The first phase response is absent in mast
cell-deficient WBB6F1-W/W
v mice (17,22) and inhibited by
antihistamines (17,23), demonstrating that the response is
dependent on mast cells and a mast cell mediator, histamine.
Fraction BW separated from mycelium of P. linteus potently
inhibited the vascular permeability increase associated with
PCA and caused by histamine injection. Vascular permeability
increase associated with PCA involves IgE-dependent mast
cell activation and histamine release, and released histamine
is responsible for the increased vascular permeability (19,20).
Therefore, BW may suppress IgE-dependent mast cell
activation and/or antagonize against histamine actions.
The second phase ear swelling in the triphasic cutaneous
reaction peaked at  24 h after the challenge is fully expressed
in mast cell-deficient mice, and inhibited by antibodies against
interleukin-1b (IL-1b) and TNF-a (21,24,25). IL-1b and
TNF-a injected into ear lobes of mice cause ear swelling
peaked at  24 h later. These results strongly suggest that
inflammatory cytokines participate in the induction of the
second phase response and that the response could be induced
mast cell-independently. In contrast, as mast cells produce
inflammatory cytokines, mast cell activation could also parti-
cipate in inducing the second phase response (26,27). In the
present results, fraction BW inhibited the ear swelling caused
by TNF-a, suggesting that inhibitory properties of BW for
inflammatory cytokine actions participate in the inhibition of
the second phase response.
The third phase ear swelling in the triphasic cutaneous reac-
tionappearsseveraldayslateranditspeakresponseisobserved
at  8 days later (14,15). The third phase response is absent in
athymic nude mice and partially reduced in mast cell-deficient
mice. The third phase ear swelling is characterized by an accu-
mulation of abundant eosinophils. Although a subpopulation
of T lymphocytes seems to play important roles in the induc-
tion of the third phase response (15), the precise mechanism
is not elucidated. In the present study, BW inhibited the third
phase response partially. Inhibition of the first phase response
by BW may contribute to its inhibition of the third phase
response, but the inhibitory mechanism involved should be
examined further.
It is well established that polysaccharides of P. linteus poten-
tiate T cell responses (6). In the present study, we examined the
effects of BW on the cytokine production of mouse spleno-
cytes stimulated with anti-CD3 antibodies. It is interesting to
note that the fraction BW potentiated the production of both
0 50 100 150
IL-4 (pg/ml)
ND
**
**
*
0 100 200 300 400
IFN-γ(pg/ml)
ND
**
**
**
**
**
0246
Recovered cells (x106 /well)
10-7 M
10-6 g/ml
Control
Spon
10-5 g/ml
10-4 g/ml
Pred 10-8 M
10-6 M
BW
Figure 6. Effects of fraction BW and prednisolone on cytokine production in mouse splenocytes. Splenocytes were incubated with anti-CD3 antibodies for 48 h in
duplicate. After the incubation, cells were recovered and counted. IL-4 and IFN-g in the supernatants were quantified by enzyme-linked immunosorbent assay.
Each value represents the mean ± SEM for four mice.
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BW may potentiate T cell cytokine production directly and/or
through augmenting accessory cell function, and the results
coincide well with the previous reports (6,8). However, the
immunopotentiating effects of fraction BW may not support
its anti-allergic effects. Therefore, effects of BW on the T cell
responses should be further examined using different
stimulants in relation to its inhibitory mechanism of the third
phase response. As the BW fraction derived from P. linteus
mycelium seems to contain high molecular weight water-
soluble constituents, such as polysaccharides, polysaccharides
of P. linteus may exhibit anti-allergic activities as well as
immunopotentiating activities.
In summary, we examined the anti-allergic activities of five
fractions prepared from mycelium of P. linteus using a mouse
allergic reaction model and found that the BW-soluble fraction
possesses potent anti-allergic activities. Furthermore, the BW
fraction also exhibits immunopotentiating activities. Polysac-
charides involved in P. linteus may be the active constituents
in the BW fraction responsible for both anti-allergic activities
and immunopotentiating activities. Identification and charac-
terization of the active constituents are now underway.
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